SCHEMBL8659042

SCHEMBL8659042

CCCC(=O)OC1CCCCC1.[Cu]

nearest known ligand 0.71

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.71
EPHX1 P07099 2/20 0.52
HTT P42858 2/20 0.50
CYP2C19 P33261 1/20 0.49
CYP19A1 P11511 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
SLC18A3 Q16572 1/20 0.40
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10033955 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL9134369 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL10033782 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1695502 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL397795 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1695757 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL9131984 0.98 NAAA (0.73) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1313739 0.96 NAAA (0.71) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL3291623 0.96 NAAA (0.71) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL6549478 0.96 NAAA (0.71) NAAAEPHX1HTTCYP2C19CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114277398-B Preparation method and application of nano copper catalyst 北京航空航天大学 2023-06-30 CN claimed
CN-114369248-A Chiral silicon-containing polyester and synthesis method thereof 中国科学院大连化学物理研究所 2022-04-19 CN claimed
EP-2621455-B1 POLYMERIZABLE DENTAL MATERIAL COMPRISING A REACTIVE PASTE FORMER, HARDENED DENTAL MATERIAL AND USE THEREOF KETTENBACH GMBH & CO KG (DE) 2019-06-26 EP claimed
CN-103068229-B Dibromomalonamide compositions and their use as biocides DOW GLOBAL TECHNOLOGIES INC 2015-05-20 CN claimed
US-20130225699-A1 Polymerizable Dental Material Comprising Reactive Paste Formers, Hardened Dental Material and Use Thereof KETTENBACH GMBH & CO. KG (DE) 2013-08-29 US claimed
CN-103068229-A Dibromomalonamide compositions and their use as biocides DOW GLOBAL TECHNOLOGIES LLC 2013-04-24 CN claimed
US-5723075-A HEAT RESISTANT ABSORBERS WITH RESINS FOR SHIELDS NIPPON PAPER INDUSTRIES CO., LTD. (JP) 1998-03-03 US claimed
US-5250641-A Using morpholine derivative, pyrimidinetrione compound, organometallics and organohalogens as aids, promoters for (meth) acrylate polymers GC DENTAL PRODUCTS CORP. (JP) 1993-10-05 US claimed
EP-0300561-A2 Method for producing superconducting oxides and thin films of such oxides Koninklijke Philips Electronics N.V. (NL) 1989-01-25 EP claimed
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2025-07-10 US disclosed
EP-4484421-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR INITIATING POLYMERIZATION, POLYMERIZATION INITIATOR, KIT FOR PREPARING CURABLE COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT AND DENTAL MATERIAL Mitsui Chemicals, Inc. (JP) 2025-01-01 EP disclosed
CN-114277398-B Preparation method and application of nano copper catalyst 北京航空航天大学 2023-06-30 CN disclosed
WO-2023106419-A1 DENTAL CURABLE COMPOSITION クラレノリタケデンタル株式会社 2023-06-15 WO disclosed
CN-114369248-B Chiral silicon-containing polyester and synthesis method thereof 中国科学院大连化学物理研究所 2022-09-02 CN disclosed
CN-103117327-A Improved method for forming metal contacts ROHM & HAAS ELECT MAT 2013-05-22 CN disclosed
CN-103068229-A Dibromomalonamide compositions and their use as biocides DOW GLOBAL TECHNOLOGIES LLC 2013-04-24 CN disclosed
CN-1211330-C Method for preparing halogenated hydrocarbons SOLVAY (BE) 2005-07-20 CN disclosed
CN-1261338-A Process for preparing halogenated hydrocarbons SOLVAY (BE) 2000-07-26 CN disclosed
US-5250641-A Using morpholine derivative, pyrimidinetrione compound, organometallics and organohalogens as aids, promoters for (meth) acrylate polymers GC DENTAL PRODUCTS CORP. (JP) 1993-10-05 US disclosed
EP-0300561-A2 Method for producing superconducting oxides and thin films of such oxides Koninklijke Philips Electronics N.V. (NL) 1989-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL PROC, THEM6, RBCK1 NAAA 2224/4885EPHX1 1830/4885HTT 2155/4885
US-20130225699-A1 Polymerizable Dental Material Comprising Reactive Paste Formers, Hardened Dental Material and Use Thereof ME1, ME2, ME3 NAAA 776/4885EPHX1 2502/4885HTT 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.